Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Vymazal

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Journal of Magnetic Resonance Imaging : JMRI|May 1, 1994
Magnetoferritin: characterization of a novel superparamagnetic MR contrast agentJ W Bulte, T Douglas, S Mann, et al.
AJNR. American Journal of Neuroradiology|March 3, 2012
Does higher gadolinium concentration play a role in the morphologic assessment of brain tumors? Results of a multicenter intraindividual crossover comparison of gadobutrol versus gadobenate dimeglumine (the MERIT Study)Z Seidl, J Vymazal, M Mechl, et al.
AJNR. American Journal of Neuroradiology|October 11, 2014
Are there differences between macrocyclic gadolinium contrast agents for brain tumor imaging? Results of a multicenter intraindividual crossover comparison of gadobutrol with gadoteridol (the TRUTH study)K R Maravilla, M P Smith, J Vymazal, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Journal of Magnetic Resonance Imaging : JMRI|May 1, 1994
Magnetoferritin: characterization of a novel superparamagnetic MR contrast agentJ W Bulte, T Douglas, S Mann, et al.
AJNR. American Journal of Neuroradiology|March 3, 2012
Does higher gadolinium concentration play a role in the morphologic assessment of brain tumors? Results of a multicenter intraindividual crossover comparison of gadobutrol versus gadobenate dimeglumine (the MERIT Study)Z Seidl, J Vymazal, M Mechl, et al.
AJNR. American Journal of Neuroradiology|October 11, 2014
Are there differences between macrocyclic gadolinium contrast agents for brain tumor imaging? Results of a multicenter intraindividual crossover comparison of gadobutrol with gadoteridol (the TRUTH study)K R Maravilla, M P Smith, J Vymazal, et al.
Pageof 5